---
title: "Final Presentation"
author: "Christian, Dea, Dilan, Mikkel"
editor: visual
format:
  revealjs: 
    theme: moon
---

# Introduction and data handling

Aim: Explore the clinical and genomic data from the METABRIC database of breast cancer, and determine which variables and genes drives overall survival of cancer.

![](images/data_handle.png){width="506"}

# Data description {.smaller .scrollable transition="slide"}

::: panel-tabset
### Data

```{r}

data <- read.table("../data/_raw/METABRIC.csv", header = TRUE, sep = ",")
names(data)
```

### Missing data

![](images/02_missing_data.png){width="789"}

### Data clean

```{r}

data_clean <- read.table("../data/clinical_data_clean.tsv", header = TRUE, sep = "\t")
names(data_clean)

```

### Age distribution

![](images/03_age_distribution.png){width="769"}

### Cancer type vs age

![](images/03_cancertype_age.png){width="776"}
:::

# Survival analysis

## Patient survival according to age groups

![](images/05_age_bar.png)

## Patient survival according to tumor size

![](images/06_age_tumor_survival_boxplot.png)

## Hormone status vs. patient survival

![](images/05_hormone_status_boxplot.png)

## Lymph Node and tumor size vs. survival

![](images/05_lymph_boxplot.png)

## Neoplasm and tumor size vs. patient survival

![](images/05_violin_plot.png)

## Therapies used by individuals alive

![](images/05_therapeutics_comp.png)

# Gene expression analysis

## PCA {.smaller .scrollable transition="slide"}

::: panel-PCA
### PCA variance

![](images/06_PCA_variance.png){width="589"}

### PCA Overall_survival

![](images/06_PCA_survival.png)

### PCA status

![](images/06_PCA_status.png){width="644"}

### PCA Therapy

![](images/06_PCA_therapy.png){width="645"}
:::

## Gene expression vs. death

![](images/06_signif_genes.png){width="726"}

# Mutation analysis

## Most abundant gene mutations in breast cancer

![](images/07_most_mutated.png)

# Conclusion/Further work

-   Age has an impact on death

-   Tumor size might be related to death but needs statistical significance test

-   The more positive lymph nodes, the more likely to not survive

-   Shorter expected survival time with a neoplasm histological grade of 3

-   Radio - and hormone therapy is the most frequently used therapy amongst patient who survived.

-   PCA and gene expression need a further investigation

-   pik3ca, tp53, muc16 and ahnak2 are the most frequently mutated genes in breast cancer
